An international consortium has combined data from 150,000 people around the globe to shed light on genetic risk factors for schizophrenia, a debilitating psychotic disorder.
Mar 04, 2015
5 / 5 (2) | 0
Cannabinoids may be involved in the weight gain that occurs in people with schizophrenia who are treated with the antipsychotic olanzapine, according to a pilot study published in the Journal of Clinical Psychopharmacology ...
Feb 05, 2015
1 / 5 (1) | 0